Banas Finance Limited Overview
Banas Finance Limited is a four-decade-old, Mumbai-based, non-deposit-taking NBFC that functions in practice as a proprietary investment and trading vehicle rather than a conventional lender. Its earnings are dominated by gains and losses on its equity investment portfolio and, since Q4 FY2024, by a commodity-trading book, with interest income from loans a small and only recently growing contributor. The company is controlled by the Agrawal family (promoter group 26.58%) and is the product of a 2020 three-way amalgamation that absorbed Proaim Enterprises, Axon Ventures and Rockon Enterprises. It raised ₹41.5 cr through a 2024 rights issue, carries virtually no debt, and trades at roughly 0.44x book value. Its defining characteristics are extreme earnings volatility (net results swinging from +₹69 cr to −₹54 cr in consecutive years), a nine-person organisation, thin disclosure, and a valuation that reflects heavy market scepticism about the quality and repeatability of earnings.
The company's own description
The company describes itself in exchange filings and on broker profiles (drawn from its annual report) as an RBI-registered non-deposit-taking NBFC engaged in "finance and share trading," and historically as being "engaged in finance, Share Trading, Investments, Consultancy and having interest in Realty business." Its memorandum objects are broad, covering purchase, leasing, factoring and hire-purchase financing of plant, machinery, vehicles, vessels, aircraft and other equipment, and acting as investors and dealers in shares, stocks and securities — explicitly excluding banking and insurance. Recent broker summaries of the annual report state the company operates a single primary segment of finance and share trading from which it derives its main revenue, and describe the company as consolidating its position after a 40-year journey (Groww summary of AR). From Q4 FY2024 onward, however, the company's own quarterly results disclose two reportable segments: (a) Finance Business Activities and (b) Commodity/Trading Business (Q1 FY2025 results filing, 10 Aug 2024).
Independent characterisation
Stripped of the broad memorandum language, Banas Finance's economic model has three components:
-
Proprietary equity investment and trading. The bulk of the balance sheet is investments (₹91 cr of ₹138 cr total assets at 31 Mar 2026, consolidated). Income from this activity is recognised through the P&L as "net gain/loss on fair value changes" and through Other Comprehensive Income (OCI) for equity instruments designated at FVOCI. This is the dominant driver of reported results: Q3 FY2026's ₹40.5 cr standalone loss was primarily a ₹39.28 cr fair-value loss on investments. In FY2026, standalone PAT was ₹6.63 cr but total comprehensive income was a loss of ₹34.27 cr — i.e., the investment book lost substantially more than the P&L shows.
-
Commodity trading. Introduced in Q4 FY2024, this is a buy-sell trading activity. It generates high gross revenue at thin or negative margins (Q3 FY2026: segment income ₹12.95 cr, segment loss ₹3.82 cr). The "cost of services provided" line rose from INR 87.1M (FY2022) to INR 424.0M (FY2026), consistent with traded-goods purchases being booked against trading revenue.
-
Lending (inter-corporate deposits / loans). Interest and dividend income was only INR 3.69M in FY2024 and INR 5.77M in FY2025, before rising to INR 38.05M in FY2026 — the first year lending became a visible contributor. Provisions for loan losses have been significant relative to this income: INR 47.9M (FY2024), INR 201.4M (FY2025), INR 99.7M (FY2026).
Revenue model mix (analyst characterisation, FY2026): No product, subscription or licensing revenue. Revenue is entirely financial and trading: fair-value/realised investment gains, commodity sales, and interest income. The company does not disclose a formal revenue-by-type split in a retrievable form; based on StockAnalysis's line items for FY2026 (INR M): interest & dividend income 38.05; gain on sale of investments 18.27; "other revenue" (largely trading and fair-value income) 538.66.
Value-chain position: Capital provider and principal trader; it does not originate retail loans, has no branch network, no co-lending arrangements, and no disclosed fee businesses.
Customer types / end-markets: Not publicly disclosed in detail. Given the scale (nine employees, no branches), lending counterparties are likely a small number of corporate borrowers (inter-corporate deposits), and trading counterparties are commodity market participants. End-market is India only.
Strategy
Stated strategy. The company does not publish an investor presentation, does not hold investor days and has no earnings calls. Broker summaries of the annual report convey three themes: (1) the company's organisational changes aim to increase stakeholder value; (2) it seeks to expand its geographical reach; and (3) it aims to contribute positively to national economic growth, framed around an aspirational philosophy about embracing ambitions (Groww summary of AR). No quantified medium-term targets — loan book, ROE, AUM, cost ratios — are disclosed.
Initiatives in the last 24 months (Oct 2024 – Oct 2026):
ESG/sustainability commitments, cost programmes, guidance: None disclosed.
Products & Services
Banas Finance has no branded products, platforms or published price schedules. The complete catalogue of disclosed activities is:
No launch years, versions or flagship offerings exist in the conventional sense; "not publicly disclosed" applies to specifications, customer counts, ticket sizes and yields.
Product Portfolio
| Segment | Offering | Description | Target counterparty | Since | Pricing | Source |
|---|---|---|---|---|---|---|
Finance | Corporate loans / inter-corporate deposits | Unsecured or secured lending to corporates; NBFC-ND licence permits lending from own funds | Corporate borrowers (identities not disclosed) | Pre-1999; scaled FY2026 | Not disclosed; FY2026 interest & dividend income INR 38.05M | StockAnalysis |
Finance | Proprietary equity investments | Holdings in listed and unlisted shares, recognised at fair value (FVTPL and FVOCI) | Own book | Long-standing | — | Q3 FY2026 results; FY2026 TCI |
Finance | Share trading | Short-term buying and selling of securities | Own book | Long-standing | — | Company description |
Finance | Associate investment | 48.84% equity stake in Tilak Ventures Limited | — | — | — | ScanX |
Commodity/Trading | Commodity trading | Buy-sell trading of commodities; type not disclosed | Market counterparties | Q4 FY2024 | — | Q1 FY2025 filing |
Other (historic) | Consultancy | Listed in company description; no revenue disclosed | — | Historic | — | Company CV |
Other (historic) | Realty interest | — | — | — | — | Company CV; Screener |
Memorandum objects (not evidenced as active) | Leasing, hire-purchase, factoring of plant, vehicles, vessels, aircraft, computers | Permitted under objects clause | — | 1983 objects | — | Screener (AR-derived) |
“—” = not publicly disclosed.
Financial Narrative
Income statement (consolidated unless stated; ₹ cr)
Gross profit: is not a meaningful metric for an NBFC and is not reported. EBITDA is approximated by operating profit before other income, interest and depreciation (depreciation is negligible; ₹0.0074 cr in FY2025). FY2026 PBT per the filing is ₹12.40 cr (₹1,239.85 lakh). EPS figures are as reported by Screener, which appears to adjust earlier years for the 2024 rights issue; unadjusted EPS on contemporaneous share counts would be materially higher for FY2022 — not separately verified.
Revenue build and cost lines
Zeros in FY2022–FY2023 interest income and FY2023/FY2025 investment-gain rows reflect the vendor showing no separate line ("–"), not necessarily nil activity.
Margins and growth (derived)
Revenue CAGR (derived): FY2022→FY2026 total income: (59.50/100.90)^(1/4) − 1 = −12.4% p.a. Screener reports a 5-year sales CAGR of 33% (FY2021 base of ~₹14 cr) and 3-year CAGR of 43% (FY2023 trough base). The choice of base year dominates the answer — itself a symptom of volatility.
Commentary. The five-year record shows no stable earnings base. FY2022's extraordinary ₹69 cr profit was almost entirely investment-driven (operating margin 93%) during the post-pandemic small-cap rally; FY2023's ₹54 cr loss reversed it as the same book was marked down (expenses of ₹120 cr against revenue of ₹20 cr, largely fair-value losses). FY2024 recovered to a modest ₹4.4 cr despite ₹34 cr PBT, owing to an unusual 93% effective tax rate (deferred tax movements of ₹30.75 cr appear in the FY2024 balance sheet per IIFL). FY2025 was a loss year with provisions for loan losses quadrupling to INR 201M — the clearest signal of credit stress in the lending book. FY2026 returned to profit at the P&L level (₹6.6–11.3 cr) with lending income becoming visible for the first time (INR 38M), but total comprehensive income was a ₹34.3 cr loss, meaning shareholders' equity shrank sharply. The inflection to watch is whether interest income can become a recurring base that dampens the fair-value swings.
Quarterly trajectory (consolidated, ₹ cr, Screener; Q3 FY2026 per filing)
Notes: Q3 FY2026 PBT and net profit are from the filing (Capital Market/Dion Global), replacing Screener's −1.22/−1.14. Q1 FY2027 net profit is the filing figure (₹286.72 lakh). Q2 FY2026 standalone net profit was reported as ₹9.33 cr (Dion Global). Q4 FY2026 net profit is reported as ₹6.81 cr by Screener/Capital Market but ₹4.46 cr by Kotak Neo — another vendor conflict. Q1 FY2026 net profit is shown as ₹10.63 cr by Screener but ₹0.69 cr by the company's Q1 FY2027 comparative (Investywise/Fyers); revenue for that quarter is ₹19.49 cr (Screener) vs ₹10.76 cr (Fyers). These differences likely reflect standalone vs consolidated and FVTPL vs FVOCI treatments and cannot be resolved without the primary filings.
Balance sheet (consolidated, ₹ cr, Screener)
Additional items: Short/long-term split of debt is not disclosed in retrievable form (borrowings are de minimis since FY2025). Cash & equivalents, goodwill and intangibles are not separately available; goodwill/intangibles are presumed nil (no acquisitions accounted under Ind AS 103 since the 2020 common-control merger). IIFL standalone data shows deferred tax liability of ₹30.75 cr (FY2024) and deferred tax asset of ₹25.30 cr (FY2023, FY2024). Net debt is not computable without cash; with ₹1 cr of borrowings it is approximately nil or negative. Working capital in the conventional sense is not meaningful for an NBFC; Screener reports working-capital days of 76 (FY2026) vs 205 (FY2025).
Commentary. The FY2025 increase in net worth to ₹182 cr was entirely the ₹41.5 cr rights issue; reserves actually fell by ₹16 cr. In FY2026 net worth fell by ₹44 cr to ₹138 cr — almost exactly the ₹34 cr comprehensive loss plus other adjustments — erasing the rights-issue capital in a single year. Book value per share fell from roughly ₹20.3 to ₹15.3. Investments fell from ₹128 cr to ₹91 cr, consistent with fair-value markdowns rather than disposals (cash from investing was a net outflow of ₹26 cr).
Cash flow (consolidated, ₹ cr, Screener)
FY2025 financing inflow of ₹36 cr reflects the rights issue (₹41.53 cr gross: 4,15,31,441 shares × ₹10) net of debt repayment (~₹5 cr). FY2026 operating cash flow of ₹24 cr is the strongest in the period (CFO/EBITDA 194% per Screener).
Ratios (derived unless stated)
Derivation notes: FY2021 net worth ₹92.42 cr and total assets ₹104 cr used as opening balances (IIFL/Screener). ROE FY2025 uses the −₹19.57 cr figure; on the ₹0.29 cr figure it would be 0.2%. ROE FY2026 on standalone PAT ₹6.63 cr would be 4.2%. Interest coverage is extreme in both directions because interest cost is tiny; it conveys little beyond "no leverage."
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Stake | Notes | Source |
|---|---|---|---|---|
Banas Finance Limited | Listed parent (NBFC) | — | All operations | BSE |
Tilak Ventures Limited | Associate (equity-accounted) | 48.84% | Contributes share of associate profit to consolidated results (₹8.47 lakh in Q3 FY2026) | ScanX Q3 FY2026 |
Subsidiaries | None disclosed | — | Consolidation arises from the associate | Q3 FY2026 results |
Segment Overview
| Segment | What it contains | Products/services | Start |
|---|---|---|---|
Finance Business Activities | Lending (loans/ICDs), investment in shares and securities, fair-value gains/losses, dividend and interest income | Corporate loans; proprietary equity portfolio | Since inception |
Commodity/Trading Business | Purchase and sale of commodities | Commodity trading (specific commodities not disclosed) | Q4 FY2024 |
Revenue by Segment
| Metric (INR Lakh) | Q1FY2025 | Q3FY2026 | Q1FY2027 |
|---|---|---|---|
Commodity/Trading segment revenue | 0 | 1,295.34 | 0 |
Finance segment revenue | 0 | 259.42 | 299.14 |
Finance segment PBT | -730.42 | 0 | 286.45 |
Commodity/Trading segment result | 0 | -381.75 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Analysis
| Item | Source A | Source B | Source C | Assessment |
|---|---|---|---|---|
FY2026 net profit | ₹6.63 cr standalone PAT (Investywise, citing BSE; same figure shown for consolidated in the Q1 FY2027 filing summary) | ₹11.33 cr consolidated (Capital Market via HDFC Sec; StockAnalysis INR 113.25M; Screener ₹11 cr) | — | Standalone PAT ₹6.63 cr is from the filing summary. The ₹11.33 cr consolidated figure is used by three data vendors. Unresolved; both shown. |
FY2025 net profit | ₹0.29 cr consolidated (Capital Market; Screener EPS ₹0.03) | −₹19.57 cr (StockAnalysis INR −195.7M; an earlier Screener snapshot showed ROE −11.6%) | −₹5.98 cr standalone (Investywise, as prior-year comparative) | Material conflict. Screener's own FY2025 quarterly figures sum to −₹6.92 cr, closest to the standalone −₹5.98 cr. |
FY2025 operating profit | −₹18 cr (current Screener) | −₹38 cr (earlier Screener snapshot) | — | Restated by vendor; current figure shown. |
Q3 FY2026 net result | −₹40.42 cr consolidated / −₹40.50 cr standalone (Capital Market; Dion Global; ScanX) | −₹1.14 cr (Screener quarterly table) | — | The filing-based −₹40.5 cr is preferred; Screener's quarter appears to exclude fair-value losses (possibly reclassified to OCI at year end). |
Q1 FY2027 net profit | ₹2.87 cr (standalone and consolidated per filing summary) | ₹4.97 cr (Screener consolidated) | — | Filing summary preferred. |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Cr, IIFL) | 97.80 | 20.44 | 66.64 | 43.23 | 57.23 |
Other income (INR Cr, IIFL) | 3.02 | 0.44 | 7.00 | 0.26 | 2.27 |
Total income as reported (INR Cr, StockAnalysis) | 100.90 | 20.88 | 73.64 | 43.48 | 59.50 |
Operating profit / EBITDA proxy (INR Cr, Screener) | 91 | -100 | 33 | -18 | 13 |
Profit before tax (INR Cr, Screener) | 92 | -100 | 34 | -18 | 12 |
Net profit – vendor consolidated (INR Cr, StockAnalysis) | 69.18 | -53.58 | 4.40 | -19.57 | 11.33 |
Basic EPS (₹, Screener, share-count adjusted) | 6.88 | -5.58 | 0.46 | 0.03 | 1.26 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Interest and dividend income (INR Mn) | 0 | 0 | 3.69 | 5.77 | 38.05 |
Gain on sale of investments (INR Mn) | 30.22 | 0 | 63.07 | 0 | 18.27 |
Other revenue incl. trading and fair value (INR Mn) | 975.71 | 202.41 | 669.33 | 429.05 | 538.66 |
Interest expense (INR Mn) | 1.09 | 0.94 | 0.87 | 0.39 | 1.98 |
Provision for loan losses (INR Mn) | -2.41 | 19.90 | 47.94 | 201.44 | 99.68 |
Employee benefits (INR Mn) | 3.47 | 12.47 | 10.93 | 22.53 | 28.71 |
Cost of services provided (INR Mn) | 87.10 | 187.97 | 330.01 | 377.13 | 424.03 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating (EBITDA proxy) margin % on revenue from ops | 93.0 | -489.2 | 49.5 | -41.6 | 22.7 |
Net margin % on total income (vendor NP) | 68.6 | -256.6 | 6.0 | -45.0 | 19.0 |
Total income growth % YoY | 805.5 | -79.3 | 252.7 | -41.0 | 36.8 |
Income Statement
| Metric | Q1FY2025 | Q2FY2025 | Q3FY2025 | Q4FY2025 | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|---|---|---|---|
Revenue from operations (INR Cr) | 6.08 | 8.20 | 30.57 | 4.10 | 19.49 | 18.99 | 12.95 | 20.81 | 2.99 |
Profit before tax (INR Cr) | -7.25 | -10.15 | -0.45 | -4.62 | 9.56 | 9.44 | -40.50 | 10.61 | 2.87 |
Net profit (INR Cr) | -6.57 | -9.53 | 0.67 | 8.51 | 10.63 | 10.99 | -40.42 | 6.81 | 2.87 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 189 | 159 | 167 | 183 | 138 |
Equity share capital (INR Cr) | 26 | 48 | 48 | 90 | 90 |
Reserves (INR Cr) | 136 | 104 | 108 | 92 | 48 |
Net worth (INR Cr) | 162 | 152 | 156 | 182 | 138 |
Borrowings (INR Cr) | 7 | 7 | 6 | 1 | 1 |
Investments (INR Cr) | 139 | 89 | 112 | 128 | 91 |
Fixed assets (INR Cr) | 0 | 0 | 0 | 9 | 9 |
Other assets incl. loans and cash (INR Cr) | 50 | 70 | 56 | 46 | 38 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | 20 | -1 | -6 | 0 | 24 |
Cash from investing activities (INR Cr) | -6 | -49 | 8 | -39 | -26 |
Cash from financing activities (INR Cr) | -4 | 44 | -1 | 36 | 0 |
Net cash flow (INR Cr) | 10 | -6 | 2 | -2 | -2 |
Capex (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Free cash flow (INR Cr) | 20 | -1 | -6 | 0 | 24 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE % (vendor NP / average net worth) | 54.3 | -34.2 | 2.9 | -11.6 | 7.1 |
ROA % (vendor NP / average total assets) | 47.2 | -30.8 | 2.7 | -11.2 | 7.1 |
ROCE % (Screener) | 67 | -61 | 21 | -10 | 8 |
Debt to equity (x) | 0.04 | 0.05 | 0.04 | 0.01 | 0.01 |
Interest coverage (x, PBT plus interest over interest) | 845 | -1,063 | 392 | -460 | 64 |
Asset turnover (x, total income / average assets) | 0.69 | 0.12 | 0.45 | 0.25 | 0.37 |
Revenue by Region (%) and Results by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India share of total income (%) | 100 | 100 | 100 |
India total income (INR Cr) | 73.64 | 43.48 | 59.50 |
India growth YoY (%) | 252.7 | -41.0 | 36.8 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Last close | ₹6.70 (19 Oct 2026) | Screener |
52-week high / low | ₹9.89 / ₹5.01 | Screener |
1-year return | −16% | Screener price CAGR |
3-year return (CAGR) | −28% p.a. (cumulative ≈ −40%; Anand Rathi cites −39.66%) | Screener; Anand Rathi |
5-year return (CAGR) | −8% p.a. | Screener |
10-year return (CAGR) | +6% p.a. | Screener |
Metric | FY2022 | FY2023 |
Net worth per share (₹, derived on 89.58M shares) | 18.1 | 17.0 |
Valuation Multiples
| Multiple | Banas Finance | Peer reference | Note |
|---|---|---|---|
P/E (TTM) | 2.8x | Industry P/E ~21x (Groww); micro-cap peer median ~21x (Value Research) | TTM profit per Screener ₹21.6 cr; on filing-based quarters TTM would be lower (and negative including Q3 FY2026's ₹40.5 cr loss — Anand Rathi shows P/E −2.13) |
P/B | 0.44x | Peer median ~0.82x (Value Research, Jun 2026) | Book value ₹15.3 |
EV/Sales (TTM) | ~1.1x (derived) | — | EV ≈ ₹61 cr (mcap ₹60 cr + ~₹1 cr debt; cash not deducted) / TTM revenue ₹56.4 cr |
EV/EBITDA (TTM) | ~3.2x (derived) | — | TTM operating profit ₹19 cr (Screener) |
Action by Date
| Date | Action |
|---|---|
29 Aug 2017 | 10:1 stock split (ex-date) |
Aug–Sep 2020 | Shares issued to transferor-company holders under amalgamation |
26 Apr 2024 | Rights issue record date (1:1 at ₹10) |
5 Jun 2024 | Rights allotment of 4,15,31,441 shares |
Analyst Conclusions
Management guidance and consensus
No guidance is issued and no consensus exists. The next scheduled datapoint is Q2 FY2027 (quarter ended 30 Sep 2026) results; the trading window closed on 1 Oct 2026, and on the company's historical cadence the board meeting is likely in mid-November 2026 (FY2026 Q2 results were approved on 14 Nov 2025).
Bull case
-
Deep asset discount with a recovering book. At 0.44x book and with Q1 FY2027 comprehensive income of +₹29.3 cr already recouping most of FY2026's ₹34.3 cr OCI loss, book value could rebuild toward ₹18–19 per share if markets hold — making the discount even wider.
-
Emergent lending earnings. Interest income rose roughly 6.6x in FY2026 to INR 38M, and FY2026 operating cash flow of ₹24 cr was the strongest in five years; a steadier lending base could reduce dependence on marks.
-
Clean balance sheet and capital optionality. With ~₹1 cr of debt, the company can lend, buy back shares or distribute without balance-sheet stress.
Bear case
-
Earnings are not "earnings." Reported profits are dominated by mark-to-market swings; FY2026's positive PAT coexisted with a ₹34 cr comprehensive loss, and the rights-issue capital raised in 2024 was effectively consumed within two years.
-
Credit quality. Provisions of INR 201M in FY2025 and INR 100M in FY2026 against much smaller interest income imply the lending book has been loss-making on a risk-adjusted basis.
-
Governance and disclosure discount is justified. Filing corrections, auditor-report revision, CFO and secretarial-auditor turnover, related-party approvals, a large public-category block holder, data conflicts across every major vendor, and no dividends despite profitable years all argue the P/B discount is structural rather than an anomaly.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | ~Nov 2026 | Whether OCI gains persist; interest income run-rate; any commodity-segment revival |
| Q3 FY2027 results | ~Feb 2027 | Year-on-year comparison against Q3 FY2026's ₹40.5 cr loss |
| FY2027 audited results | ~May 2027 | Full-year TCI vs PAT; provisions; net worth per share |
| Shareholding patterns | Quarterly | Any change in Prismx Global Ventures' 23.12% or promoter 26.58% |
| Related-party transactions | AR FY2027 | Nature and size of transactions approved at 2026 AGM |
| Regulatory | Ongoing | RBI scale-based regulation compliance; any BSE/SEBI queries |
| Capital allocation | Any time | Dividend initiation or buyback (would signal governance improvement) |
| Management stability | Ongoing | Tenure of new CFO; company-secretary disclosure |
Analyst verdict
Banas Finance Limited is best understood not as a lender but as a small, family-controlled, listed investment vehicle wearing an NBFC licence. Its five-year record — a ₹69 cr profit, a ₹54 cr loss, a marginal year, a disputed loss year and a modest profit accompanied by a ₹34 cr comprehensive loss — demonstrates that the business has no stable earnings engine. The commodity-trading diversification launched in early 2024 has added revenue without adding profit, and the small lending book has, on the available numbers, generated more provisions than interest over FY2025–FY2026.
The valuation already reflects much of this. At roughly ₹60 cr of market value against ₹138 cr of book equity, investors are paying about 44 paise per rupee of stated net assets, and the near-absence of debt means there is little balance-sheet risk of permanent capital impairment from leverage. The early-FY2027 recovery in investment marks and the step-up in interest income are genuine, if early, positives, and a new CFO with consolidation and compliance experience could improve financial reporting.
Yet the discount is unlikely to close on fundamentals alone. Value realisation at a sub-book holding company typically requires a catalyst — dividends, buybacks, asset sales or a credible, scaled lending strategy — and none has been announced. Meanwhile the governance signals (filing corrections, auditor-report revision, management turnover, related-party approvals, a large public-category block holder) and the striking inconsistency of the company's financials across every data provider argue for caution about whether book value itself is reliable.
Verdict: a speculative, event-dependent deep-value situation with low information quality. Absent a capital-return or strategic catalyst, the base case is that the stock continues to trade at a wide discount to book, with quarterly results driven by small-cap equity market direction rather than by the company's own operating performance.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Designation | Since | Background | Age | Source |
|---|---|---|---|---|---|
Mrs. Tanu Girraj Agrawal (DIN 00290966) | Executive Director & CEO; promoter | Director long-standing; CEO from Jan 2024 | B.Sc.; previously MD (from 1 Aug 2018) and Chairman/CEO of Rockon Enterprises Ltd (merged into Banas 2020) | ~56 (aggregator) | BSE 30 Jan 2024; Simply Wall St |
Mr. Girraj Kishor (G K) Agrawal | Executive Director; promoter | Long-standing | Chartered Accountant; experience in taxation, corporate law, ICDs, bill discounting, project and hire-purchase finance; spouse of Tanu Agrawal; described as heading the board and overseeing finance and administration | — | BSE 16 Jan 2024; InvestYadnya |
Mr. Vikash (Vikas) Kulhriya | Independent Non-Executive Director | 31 Dec 2020; reappointed for second term at AGM 24 Sep 2026 | — | — | TheCompanyCheck; BSE 24 Sep 2026 |
Mr. Ashish Kachhara | Independent Non-Executive Director | Not disclosed (aggregator tenure ~2.8 years as of 2025) | — | — | Blinkx; Simply Wall St |
Mr. Anant Chourasia (DIN 09305661) | Non-Executive Director (appointed Jan 2024 as Non-Independent; later aggregators list him as Independent — designation conflict) | 16 Jan 2024 (additional); 30 May 2024 (regularised) | B.Com, MBA (Marketing & Finance); MD of Indian Infotech & Software Ltd (from Aug 2024); director at Surya Industrial Corp and Equilateral Enterprises | — | BSE 16 Jan 2024; MarketScreener; Directors' Report FY2025 |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Role | Tenure | Note | Source |
|---|---|---|---|---|
Tanu Agrawal | CEO | Jan 2024 – present | Also Executive Director | BSE |
Praveen Jangid | Chief Financial Officer | 29 Jun 2026 – present | ~10 years' experience in accounting operations, statutory compliance, consolidation, cash-flow management | ScanX; Groww |
Amit Mehta | Former CFO | to 31 Mar 2026 | Resigned (letter 16 Mar 2026), personal reasons | Screener; ScanX |
Company Secretary & Compliance Officer | — | ~6 years per aggregator | — | MarketsMojo; Simply Wall St |
Board of Directors by Person
| Person | Role | Salary (INR Mn) | Bonus (INR Mn) | Stock (INR Mn) | Total (INR Mn) | Source |
|---|---|---|---|---|---|---|
Tanu Agrawal | CEO & ED | 8.40 | 0 | 0 | 8.40 | Simply Wall St (S&P data, FY2024/25) |
Company Secretary | CS & Compliance Officer | 0.675 | 0 | 0 | 0.675 | Simply Wall St |
Vikash Kulhriya | Independent Director | 0.096 (fees) | 0 | 0 | 0.096 | Simply Wall St |
Other Independent Director | Independent Director | 0.096 (fees) | 0 | 0 | 0.096 | Simply Wall St |
Governance Detail
| Category | Sep2023 | Mar2024 | Jun2024 | Mar2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|
Promoter and promoter group % | 17.59 | 17.59 | 26.58 | 26.58 | 26.58 | 26.58 |
DIIs % | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 |
FIIs % | 0 | 0 | 0 | 0 | 0 | 0 |
Public % | 82.37 | 82.36 | 73.39 | 73.39 | 73.38 | 73.39 |
Number of shareholders | 43,140 | 38,801 | 40,844 | 39,356 | 36,692 | 36,206 |
Major Shareholders
| Holder | Category | Shares | Stake % | As of | Source |
|---|---|---|---|---|---|
Prismx Global Ventures Limited | Public (non-promoter body corporate) | ~20.7 M (derived) | 23.12 | Mar 2026 | MarketsMojo |
Handful Investrade Pvt Ltd | Promoter group | 9.563 M | 10.68 | Sep 2025 | Emkay/Dion Global |
Hunnar Jewels | Promoter group | 9.383 M | 10.48 | Sep 2025 | Emkay/Dion Global |
Girraj Kishor Agrawal | Promoter (individual) | 2,690,966 | 3.00 | Dec 2025 | Emkay/BSE SHP |
Tanu Agrawal | Promoter (individual) | 2,173,270 | 2.43 | Dec 2025 | Emkay/BSE SHP |
Domestic institutions (aggregate) | DII | — | 0.03 | Jun 2026 | Upstox |
Mutual funds / FIIs | — | 0 | 0 | Jun 2026 | Upstox |
Competitive Landscape
Key Competitors
| Peer | Segment overlap | Scale indicator | Relative positioning | Source |
|---|---|---|---|---|
Bajaj Finance | Lending (retail/SME) | Market cap ~₹6.5 lakh cr; annual PAT ~₹19,017 cr | Category leader; no practical overlap | Fyers peer table |
Shriram Finance | Vehicle/MSME lending | Market cap ~₹2.47 lakh cr; PAT ~₹10,024 cr | No practical overlap | Fyers |
Cholamandalam Investment & Finance | Vehicle/home/SME lending | Market cap ~₹1.59 lakh cr; PAT ~₹5,233 cr | No practical overlap | Fyers |
Tata Capital | Diversified lending | Market cap ~₹1.58 lakh cr; PAT ~₹4,846 cr | No practical overlap | Fyers |
Jio Financial Services | Diversified financial services / investments | Market cap ~₹1.57 lakh cr; PAT ~₹1,561 cr | Investment-holding model is conceptually closest of the large peers | Fyers |
Muthoot Finance | Gold loans | Market cap ~₹1.18 lakh cr; PAT ~₹10,590 cr | No practical overlap | Fyers |
Charter Capital | Micro-cap NBFC/investment | — | Direct micro-cap peer | MarketsMojo peer list |
Kapil Raj Finance | Micro-cap NBFC | — | Direct micro-cap peer | MarketsMojo |
Real Touch Finance | Micro-cap NBFC | — | Direct micro-cap peer | MarketsMojo |
Ceejay Finance | Small vehicle-finance NBFC | — | Small-lender peer | MarketsMojo |
Tilak Ventures | Associate; micro-cap NBFC | — | Related party, not competitor | ScanX |
Peer Comparison FY2026
| Metric | Banas Finance | Bajaj Finance | Shriram Finance | Cholamandalam |
|---|---|---|---|---|
Market cap (INR Cr) | 60 | 650,674 | 246,828 | 158,685 |
Annual PAT (INR Cr) | 11 | 19,017 | 10,024 | 5,233 |
P/E (x) | 2.8 | 32.1 | 21.8 | 27.6 |
R&D intensity (%) | 0 | 0 | 0 | 0 |



